| Literature DB >> 19804366 |
Mette Dahl Andersen1, Marianne Kjalke, Susanne Bang, Inger Lautrup-Larsen, Peter Becker, Asser Sloth Andersen, Ole Hvilsted Olsen, Henning R Stennicke.
Abstract
Coagulation factor XIII (FXIII) is activated by thrombin and catalyses crosslinking between fibrin monomers thereby providing mechanical strength to the fibrin network. V34L is a common FXIII-A polymorphism found in the activation peptide. FXIII-A V34L is activated faster by thrombin and provides formation of a tighter clot at fibrinogen concentrations in the low end of the physiological range. FXIII-A variants with potentially increased activation rates were generated. Introduction of an optimal thrombin cleavage site, V34L+V35T, increased the activation rate 7.6-fold and facilitated the formation of a fibrin network more resistant to fibrinolysis than obtained with wt FXIII-A. In contrast, introduction of fragments of fibrinopeptide A into the activation peptide resulted in severely impaired activation rates.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19804366 DOI: 10.1515/BC.2009.142
Source DB: PubMed Journal: Biol Chem ISSN: 1431-6730 Impact factor: 3.915